• Health Catalyst Invests In healthfinch

    To kick off the third quarter, Health Catalyst has announced its second acquisition of 2020. On July 9, the company announced it acquired healthfinch, Inc. for roughly $40 million. healthfinch provides a workflow integration engine delivering insights and analytics into EMR workflows to automate physicians’ ability to close patient care gaps in... Read More »
  • Second Quarter Healthcare M&A Activity Drops

    The decline in second quarter healthcare M&A probably won’t surprise many of our readers. The second quarter was the first full quarter of healthcare M&A in the shadow of the COVID-19 pandemic, and deal making took a hit as a result, as shown in results from our DSO database. Compared with Q1:20, Q2:20 dropped 20%, with 322 transactions... Read More »
  • Sanofi Inks New Licensing Deal

    Just weeks following its agreement with Translate Bio (NASDAQ: TBIO) for COVID-19 vaccine development, Sanofi (NYSE: SNY) has a new agreement with Kymera Therapeutics Inc. Sanofi and Kymera are signing a multi-program collaboration to develop and commercialize first-in-class protein degrader therapies targeting IRAK4 in patients with... Read More »
  • Summit BHC Expands Into West Virginia

    Private equity-backed Summit BHC has announced a new acquisition in West Virginia. The behavioral health treatment company added Highland Hospital to its network for an undisclosed sum. Meridian Behavioral Health Systems, LLC is selling Highland Hospital, an inpatient psychiatric facility (131 beds) with 24 beds dedicated to psychiatric... Read More »
  • Health Care M&A Deals, July 10, 2020

    The Health Care M&A deals chart is a selection of transactions announced during the prior week(s). The M&A transactions presented here are from our Deal Search Online database, which is updated daily to provide our subscribers with the most up-to-date information and trends in the healthcare industry. The largest deal of the week based on... Read More »
Mednax Sells American Anesthesiology

Mednax Sells American Anesthesiology

Deal making is getting more creative in the time of COVID-19. Mednax, Inc. (NYSE: MD) sold its anesthesiology group, American Anesthesiology, Inc., to North American Partners in Anesthesia (NAPA), a portfolio company of American Securities, for $50 million. In an 8k filing on May 6, Mednax added a few terms to that $50 million price. It retained the accounts receivable of American Anesthesiology, which, net of various other working capital items, which were approximately $110 million as of March 31, 2020. It also retained a contingent economic interest in the success of NAPA with a value ranging from $0 to $250 million based upon the multiple of invested capital returned to NAPA’s owners... Read More »

The MACRA Effect Keeps Building

Last year, the Centers for Medicare and Medicaid Services asked for comments and then rolled out the final rules on the implementation of the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA). Many industry observers predicted the rules would drive the majority of independent physician practices “right into the arms” of a local hospital, health system or other entity. Those predictions appear to be true. As of mid-March 2017, 46 acquisitions of physician practices have been announced, a 105% increase from the same period a year ago. Only one of the deals disclosed a price,  Optum’s (NYSE: UNH) $3.3 billion acquisition of Surgical Care Affiliates Inc. (NASDAQ: SCAI).... Read More »
MEDNAX Moves into Radiology

MEDNAX Moves into Radiology

It’s been a while since MEDNAX (NYSE: MD) surprised the healthcare industry with its $500 million acquisition of Virtual Radiologic Corporation (NASDAQ: VRAD). Since May 2015, in fact. Consider the wait over. The MEDNAX M&A juggernaut is rolling into the radiology arena. The acquisition of vRad added approximately 350 radiologists to MEDNAX’ payroll back then, at an average of $1.4 million per radiologist. It also added a telemedicine component, which was previously missing from MEDNAX’ dealings with hospitals on behalf of its anesthesiology and neonatology divisions. Essentially, vRad physicians read and interpret more than 5 million diagnostic imaging studies... Read More »

MEDNAX Makes 10

MEDNAX (NYSE:MD) hit the big 10 in August 2016, with its tenth acquisition of the year. The serial acquirer picked up privately-held Associated Anesthesiologists of Reno, P.C., the largest anesthesia practice in northern Nevada, offering anesthesia care across a broad range of subspecialties, including orthopedic, obstetric, pediatric and cardiac and critical care. MEDNAX continues to capitalize on anesthesiology practices’ need to become a part of a larger organization in order to meet the data and technology capabilities that hospitals are asking of them, and this purchase marks its sixth anesthesiology acquisition of the year. Outside of anesthesiology, MEDNAX acquired privately-held... Read More »

Q2:16 Results Defy Brexit and Other Uncertainties

You’ve seen the headlines: Global mergers and acquisitions slid in the first half of 2016, as did the combined value. The number of middle market deals completed in the second quarter fell to levels not seen since 2009. Buyers are walking away from targets that could be affected by sudden changes in tax regulations. It’s all thanks to Brexit and the U.S. presidential election. Then there’s the healthcare market. Deal volume actually increased compared with the previous quarter in 2016, and the same quarter a year ago. Deal volume for Q2:16 reached 396 announced transactions, up 11% versus Q1:16’s 358 deals, and 15% higher than last year’s 344 deals in the second quarter. For the first half... Read More »